African-American and Caucasian "non-responders" have similar biochemical and virologic response patterns to interferon plus ribavirin therapy for chronic HCV infection.

被引：0
|
作者：
Yee, LJ [1 ]
Langner, RG [1 ]
Kaslow, RA [1 ]
Van Leeuwen, D [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1633
引用
收藏
页码：568A / 568A
页数：1
相关论文
共 50 条
  • [1] Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
    Pianko, S
    McHutchison, JG
    Gordon, SC
    Heaton, S
    Goodman, ZD
    Blatt, LM
    Cortese, CM
    Bacon, B
    HEPATOLOGY, 2000, 32 (04) : 371A - 371A
  • [2] Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders
    Hasan, F
    Asker, H
    Al Shamali, M
    Al Kalaoui, M
    Al Nakib, B
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1642 - 1644
  • [3] Combination therapy with interferon-α 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection
    Kallinowski, B
    Liehr, H
    Moeller, B
    Stremmel, W
    Wechsler, JG
    Wiese, M
    Goeser, T
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (03): : 199 - +
  • [4] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [5] Sustained virologic response with albinterferon alfa-2b/ribavirin treatment in prior interferon therapy non-responders
    Nelson, David R.
    Rustgi, Vinod K.
    Balan, Vijayan
    Sulkowski, Mark
    Davis, Gary L.
    Muir, Andrew
    Lambiase, Louis
    Dickson, Rolland C.
    Wiesner, Russell H.
    McHutchison, John G.
    Pulkstenis, Erik
    Cronin, Patrick
    Subramanian, G. M.
    HEPATOLOGY, 2007, 46 (04) : 256A - 256A
  • [6] The direct trial (daily-dose consensus interferon and ribavirin: efficacy of combined therapy): Treatment of non-responders to previous pegylated interferon plus ribavirin: Sustained virologic response data
    Bacon, Bruce
    Regev, Arie
    Ghalib, Reem H.
    Morelli, Giuseppe
    Rothstein, Kenneth D.
    Shiffman, Mitchell L.
    Hossanein, Tarek
    Hammond, Janet
    HEPATOLOGY, 2007, 46 (04) : 311A - 312A
  • [7] Comparison of peginterferon plus ribavirin with or without induction therapy for the treatment of chronic hepatitis C (HCV) non-responders
    Bzowej, N
    Gish, R
    Wakil, AED
    Brooks, L
    Shaffer, M
    Temkin, SKA
    Leung, J
    GASTROENTEROLOGY, 2002, 123 (01) : 76 - 76
  • [8] Early Virological Response with Consensus Interferon and Ribavirin in HCV Genotype 3 Non-Responders and Relapsers to Pegylated Interferon Based Therapy
    Shakir, Tanzila
    Abbas, Zaigham
    Memon, Sadik
    Tayyab, Ghias
    Shaikh, Kashif
    Nasir, Bilal
    Hassan, Ghias
    Subhan, Amna
    Hamid, Saeed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S122 - S123
  • [9] HCV clearance patterns in saliva and serum of patients with chronic HCV infection under interferon plus ribavirin therapy
    Dios, PD
    Castro, A
    Rodríguez, I
    Reforma, NG
    Castro, M
    Eirea, M
    Hermida, M
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (05) : 308 - 311
  • [10] High and daily dosing therapy with consensus interferon plus ribavirin for combination therapy non-responders with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    HEPATOLOGY, 2001, 34 (04) : 582A - 582A
12345